Mya Thomae

Consultant / Advisor at

Delfi Diagnostics, Inc.

Health Technology

Health Services

Consumer Services

Profile

Mya Thomae is the founder of Myraqa, Inc. which was founded in 2008.
She held the title of Chief Executive Officer from 2008 to 2014.
Currently, she is a Regulatory Advisor at Delfi Diagnostics, Inc. since 2019.
In the past, she worked as a Director at Transgenomic, Inc. from 2015 to 2017, Manager-Regulatory Affairs at Chiron Corp.
from 1996 to 1997, and Manager-Regulatory Affairs at Epitope, Inc. from 1992 to 1995.
She also served as Vice President-Regulatory Affairs at Illumina, Inc. from 2014 to 2017.
Ms. Thomae has also founded HX Diagnostics, Inc. and served as Vice President-Regulatory & Clinical Affairs.
She was also an Advisor at Illumina Accelerator.
Ms. Thomae received her undergraduate degree from the University of Wisconsin.

Mya Thomae active positions

Companies	Position	Start
Delfi Diagnostics, Inc. Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws	Consultant / Advisor	01/10/2019

All active positions of Mya Thomae

Former positions of Mya Thomae

Companies	Position	End
Transgenomic, Inc. Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases	Director/Board Member	28/06/2017
ILLUMINA, INC.	General Counsel	01/06/2017
Myraqa, Inc. Myraqa, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic services	Chief Executive Officer	01/07/2014
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	General Counsel	01/01/1997
Epitope, Inc. Epitope, Inc. Medical SpecialtiesHealth Technology Develops diagnostic tests and related products	General Counsel	01/01/1995

See the detail of Mya Thomae's experience

Training of Mya Thomae

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mya Thomae's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Health Technology
Epitope, Inc. Epitope, Inc. Medical SpecialtiesHealth Technology Develops diagnostic tests and related products	Health Technology
Transgenomic, Inc. Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases	Health Technology
Illumina, Inc. Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments	Health Technology
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
HX Diagnostics, Inc. HX Diagnostics, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic services for infectious diseases	Health Services
Myraqa, Inc. Myraqa, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic services	Health Services
Illumina Accelerator Illumina Accelerator Investment ManagersFinance Illumina Accelerator invests in companies located across the globe. The firm targets companies operating in the fields of genomics, including novel therapeutics, agriculture, synthetic biology, software and direct-to-consumer applications. The firm provides financing for seed and early-stage capital requirements with an investment size up to USD 0.2 million.	Finance
Delfi Diagnostics, Inc. Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws	Health Technology

See company connections